Press Releases
 
Skin and Soft Tissue Infection Treatment Market Size, Application Analysis, Regional Outlook, 2016-2

Market for skin and soft tissue infections treatment is analyzed based on the medications used for its treatment; New product developments will drive the skin and soft tissue infections treatment market

, 25 March 2019 -- Market for skin and soft tissue infections treatment is analyzed based on the medications used for its treatment; New product developments will drive the skin and soft tissue infections treatment market

Skin and Soft Tissue Infection Treatment Market: Overview

Skin and soft tissue infections (SSTIs) are one of the most common infections present in inpatient as well as outpatients. Skin and soft tissue infections (SSTIs) comprise of various minor and major infections of skin, fascia, subcutaneous tissue and muscle. These infections include such as impetigo, folliculitis, furuncles, carbuncles, erysipelas, cellulitis, necrotizing fasciitis and pyomyositis. These infections may be associated with an underlying cause such as diabetes or systemic immunosuppression.

Skin and soft tissue infections (SSTIs) may be caused by any of the pathogenic microorganisms which include Staphylococcus aureus, Streptococcus pyogene, gram-negative bacilli, Pseudomonas aeruginosa, beta-hemolytic streptococci, Enterococcus, streptococci, staphylococci, Peptostreptococcus, Bacteroides, Clostridium and S. pyogenes. Methicillin-resistant Staphylococcus aureus (MRSA) and streptococci are the most common organisms causing skin and soft tissue infections (SSTIs).

Report Overview @ https://www.transparencymarketresearch.com/skin-soft-tissue-infection-treatment-market.html

Skin and Soft Tissue Infection Treatment Market: Segmentation

The market for skin and soft tissue infections treatment is analyzed based on the medications used for its treatment which includes antibiotics and anti-fungal agents. Traditionally, use of beta-lactam antibiotics has proved to be beneficial against various skin and soft tissue infections. However, with rising use of these traditional medications has led to resistance of these bacteria against the beta-lactam antibiotics.

Moreover, new strains of infectious bacteria urge the need for development of new therapies. Consequently physicians have started using the third-generation antibiotics such as cephalosporins, fluoroquinolones or extended-spectrum agents such as amoxicillin and clavulanic acid. The selection of an appropriate drug depends on the causative microorganism. Besides medications, imaging tools and surgical methods are also practiced for the treatment of skin and soft tissue infections (SSTIs).

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13349

Skin and Soft Tissue Infection Treatment Market: Key Trends

The rising incidence of Methicillin-resistant Staphylococcus aureus (MRSA) infections has resulted in the need for new therapies to combat the serious skin and soft tissue infections. In addition, new product developments will drive the skin and soft tissue infections treatment market. Recently, in February 2014, Cubist Pharmaceuticals, Inc. announced that its Marketing Authorization Application (MAA) for investigational candidate tedizolid phosphate has been accepted by the European Medicines Agency (EMA) for review. With a decision expected from the European Commission (EC) during the first half of 2015, the company seeks to market its new product for the treatment of skin and soft tissue infections.

Prior to EMA, the U.S. FDA accepted company’s New Drug Application (NDA) for review and the company had also planned for submitting a New Drug Submission (NDS) in Canada in 2014 for tedizolid intended for the treatment of skin and soft tissue infections. Moreover, in December 2013, Durata Therapeutics, Inc. announced the acceptance of its Marketing Authorization Application (MAA) for dalbavancin, intended for the treatment of skin and soft tissue infections, by the European Medicines Agency (EMA) for review.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=13349

The Infectious Diseases Society of America has recently released guidelines for the diagnosis and management of skin and soft tissue infections (SSTIs). This practice guideline is to guide the physicians in proper diagnosis and efficient treatment of the skin and soft tissue infections and avoid serious consequences. Based on geography, the skin and soft tissue infections treatment market is analyzed into North America, Europe, Asia-Pacific and Rest of the World.

Skin and Soft Tissue Infection Treatment Market: Key Players

Some of the companies engaged in the development of skin and soft tissue infection (SSTI) treatment medications include Cubist Pharmaceuticals, Inc., Wockhardt Limited, Atox Bio Inc., Durata Therapeutics, Inc., Basilea Pharmaceutica AG, and Melinta Therapeutics Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email:

Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Monday, 25 March 2019 at 6:28 PM
Category: Health Care & Medical
 
Related News

Hepatitis Therapeutics Market Review with Forecast Research Report 2018 - 2026
Saturday, 20 Jul 2019

Cranial & Auricular Electrostimulation Devices Market Scope and Opportunities Analysis 2018 –
Saturday, 20 Jul 2019

Compounding Pharmacy Market Growth and Sales Forecast 2018 - 2026
Saturday, 20 Jul 2019

Drug Discovery Services Market Size, Share & Trend | Industry Analysis Report, 2026
Saturday, 20 Jul 2019

Facial Aesthetic Devices Market Growth and Sales Forecast 2018 - 2026
Saturday, 20 Jul 2019

Related Events

Oncology Review
Saturday, 20 Jul 2019

Mammary Carcinoma Update 2019 - A continuing education series from the MCI Academy
Saturday, 20 Jul 2019

Breast Imaging A to Z: How to Read Like (or Better Than) the Experts-Hawaii
Monday, 22 Jul 2019

Update in Orthpaedic Surgery Conference July 22-25, 2019 Grand Hyatt Kauai
Monday, 22 Jul 2019

Echocardiographic Symposium at Vail
Monday, 22 Jul 2019

Latest News

Global Prebiotics Market Research Report 2019-2029
Saturday, 20 Jul 2019

Web Designing - An Crucial Technique to Market Your Business
Saturday, 20 Jul 2019

Guberman-PMC Stands Proudly as the Only Independent Quality & ISO Consulting Firm Free From Foreign
Saturday, 20 Jul 2019

Collection of Northwest Art to Be Sold By McLaren Auction Service’s August 1st, 2019 Fine Art
Saturday, 20 Jul 2019

Wedding is like a Deck of Cards
Saturday, 20 Jul 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Saturday, 20 July 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Oncology Review
  • Mammary Carcinoma Update 2019 - A continuing education series from the MCI Academy
  • Breast Imaging A to Z: How to Read Like (or Better Than) the Experts-Hawaii
  • Update in Orthpaedic Surgery Conference July 22-25, 2019 Grand Hyatt Kauai
  • Echocardiographic Symposium at Vail

  • Latest Jobs
    Sorry, there are currently no entries posted here.